Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial
Below-Label Microdosing FDA-approved medications already use gradual initiation and dose escalation to help patients adjust to treatment
Berberine has blood sugar-lowering properties similar to metformin, and combining it with a GLP-1 medication could increase hypoglycemia risk
When eNOS knockout mice are subjected to experimental varicocele induction, impaired NO production appears to aggravate vascular dysfunction and testicular injury, suggesting that eNOS-derived NO is essential for preserving local blood flow, endothelial integrity, and tissue homeostasis under varicocele-related stress conditions (122, 123)
IV therapy makes sense in specific circumstances: GI absorption issues (IBS, IBD, post-bariatric, celiac), acute high-demand windows (illness recovery, event preparation, peak training), need for rapid serum restoration (severe dehydration, post-event), patients on medications that impair absorption (PPIs, metformin), and patients who simply have not responded adequately to oral supplementation under physician guidance